A Microneedling and Serum Acne Treatment Study

Unknown Phase 2,Phase 3 NCT06602284

Study Description

Evaluating the Effectiveness of Dermapen 4™ Microneedling Device and MG-CLR Serum for Acne Treatment Over 12 Weeks

Study Details

Registry ID:
NCT06602284
Conditions:
Acne
Phase:
Phase 2,Phase 3
Target Enrollment:
10 participants
Start Date:
Age Range:
18–45 years
Gender:
Female
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →